FBInvestor
Stocks / Tenaya Therapeutics Inc
Institutional Ownership

Tenaya Therapeutics Inc

CUSIP 87990A106COMTNYAQ1 2026

13D / 13G Filings
40
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
32.0%
Max % of class reported
Institutional Holders
100
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

40 filings · latest Feb 26, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 26, 2026The Column Group III, LP13D/A23.1%SEC
2Feb 12, 2026The Column Group III, LP13D/A25.4%SEC
3Dec 17, 2025The Column Group III, LP13D/A23.1%SEC
4Aug 14, 2025Woodline Partners LP13G/A5.0%9.00MSEC
5Jul 31, 2025Empery Asset Management, LP13G/A5.0%8.30MSEC
6Jul 16, 2025Blackrock, Inc.13G/A1.7%2.73MSEC
7May 15, 2025Woodline Partners LP13G6.8%5.92MSEC
8May 14, 2025The Column Group III, LP13D/A30.3%SEC
9May 7, 2025Empery Asset Management, LP13G10.0%8.73MSEC
10Mar 7, 2025The Column Group III, LP13D/A32.0%SEC

30 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Tenaya Therapeutics Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →